Latest ventricular tachycardia Stories
New research has found that the answer to treating a rare inherited heart disorder could lie with a drug already on the market. Associate Professor Derek Laver from the University of Newcastle and international colleagues have found that Flecainide
LA JOLLA, Calif., March 4 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced today that it has filed a formulation patent covering its lead product, ATPace. ATPace is a stable liquid formulation of adenosine triposphate (ATP) for intravenous administration.
LA JOLLA, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced today that it has submitted to the U.S. Food and Drug Administration (FDA) an amended Phase 3 protocol for ATPace to be reviewed as a Special Protocol Assessment (SPA).
Conference call scheduled for Friday, February 20, at 10:00 a.m. EST LA JOLLA, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) will host a teleconference on Friday, February 20, at 10:00 a.m.
Stock to trade under new ticker symbol 'CDXP.OB' LA JOLLA, Calif., Jan. 28 /PRNewswire-FirstCall/ -- Duska Therapeutics, Inc. (OTC Bulletin Board: DSKA) announced today that it has completed a corporate name change to Cordex Pharma, Inc.
KING OF PRUSSIA, Pa., Jan. 5 /PRNewswire/ -- Prism Pharmaceuticals announced today that the U.S.
BIOTRONIK, the pioneer in wireless remote monitoring technology for patients with cardiac devices, announced today that data presented at the New Trials in Electrophysiology and Pacing Session of the American Heart Association (AHA) 2008 Scientific Sessions shows remote monitoring of its implantable cardioverter defibrillators (ICD) is a safe and effective alternative to conventional in-office follow-up care, which helps reduce the burden on capacity-constrained cardiac centers.
In a multicenter study, catheter ablation has been shown in a randomized clinical trial to significantly outperform anti-arrhythmic drug (AAD) therapy for the treatment of symptomatic paroxysmal atrial fibrillation.
Thermedical, a privately held company currently developing a proprietary ablation therapy for the treatment of cancer, announced today that it has received a $3.6 million Competing Phase 2 Renewal Grant from the National Heart, Lung and Blood Institute.
By Walker, Dennis D Johnson, Monica L; Craig-Gray, Robert W; Loyd, Frank ABSTRACT Introduction: Brugada syndrome describes a subgroup of patients at risk for polymorphic ventricular tachycardia, ventricular fibrillation, and sudden cardiac death and is likely underdiagnosed among aviators.
The precordial thump is an application of mechanical energy through a calculated strike to the torso when in a specific fatal heart rhythm. This procedure is used in very specific circumstances by highly trained health professionals with ACLS certifications. The Procedure While in the presence of a patient that is suffering a potentially fatal heart rhythm, a medical provider can strike a calculated point on the sternum to disrupt that rhythm. The energy transferred by the provider is...